Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Equity: 2019-2025

Historic Return on Equity for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to 0.28%.

  • Eton Pharmaceuticals' Return on Equity rose 9.00% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 9.00%. This contributed to the annual value of 0.19% for FY2024, which is 13.00% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Return on Equity stood at 0.28% for Q3 2025, which was down 66.42% from 0.17% recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Return on Equity high stood at 0.13% for Q3 2023, and its period low was 0.90% during Q2 2022.
  • Its 3-year average for Return on Equity is 0.19%, with a median of 0.19% in 2025.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Return on Equity soared by 487bps in 2021, and later crashed by 63bps in 2022.
  • Eton Pharmaceuticals' Return on Equity (MRQ) stood at 0.12% in 2021, then plummeted by 533bps to 0.74% in 2022, then soared by 92bps to 0.06% in 2023, then crashed by 227bps to 0.19% in 2024, then plummeted by 50bps to 0.28% in 2025.
  • Its Return on Equity was 0.28% in Q3 2025, compared to 0.17% in Q2 2025 and 0.19% in Q1 2025.